INmune Bio, Inc. (INMB) Misses Q3 EPS by 8c
INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.60), $0.08 worse than the analyst estimate of ($0.52).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.60), $0.08 worse than the analyst estimate of ($0.52).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.